These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22186791)

  • 21. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer.
    Han J; Wang Q; Zhang Z; Gong T; Sun X
    Small; 2014 Feb; 10(3):524-35. PubMed ID: 24106138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
    Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD; Huang L
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted nanoparticles deliver siRNA to melanoma.
    Chen Y; Bathula SR; Yang Q; Huang L
    J Invest Dermatol; 2010 Dec; 130(12):2790-8. PubMed ID: 20686495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biocompatible and colloidally stabilized mPEG-PE/calcium phosphate hybrid nanoparticles loaded with siRNAs targeting tumors.
    Gao P; Zhang X; Wang H; Zhang Q; Li H; Li Y; Duan Y
    Oncotarget; 2016 Jan; 7(3):2855-66. PubMed ID: 26625203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice.
    Guo J; Ogier JR; Desgranges S; Darcy R; O'Driscoll C
    Biomaterials; 2012 Nov; 33(31):7775-84. PubMed ID: 22828585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic delivery of small interfering RNA by use of targeted polycation liposomes for cancer therapy.
    Kenjo E; Asai T; Yonenaga N; Ando H; Ishii T; Hatanaka K; Shimizu K; Urita Y; Dewa T; Nango M; Tsukada H; Oku N
    Biol Pharm Bull; 2013; 36(2):287-91. PubMed ID: 23370357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.
    Chen Y; Zhu X; Zhang X; Liu B; Huang L
    Mol Ther; 2010 Sep; 18(9):1650-6. PubMed ID: 20606648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a carrier system containing hyaluronic acid and protamine for siRNA delivery in the treatment of melanoma.
    Yang J; Zhao R; Feng Q; Zhuo X; Wang R
    Invest New Drugs; 2021 Feb; 39(1):66-76. PubMed ID: 32794135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
    Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
    Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo.
    Frede A; Neuhaus B; Klopfleisch R; Walker C; Buer J; Müller W; Epple M; Westendorf AM
    J Control Release; 2016 Jan; 222():86-96. PubMed ID: 26699423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer.
    Chen WH; Lecaros RL; Tseng YC; Huang L; Hsu YC
    Cancer Lett; 2015 Apr; 359(1):65-74. PubMed ID: 25596376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degradable poly(ethylene glycol) (PEG)-based hydrogels for spatiotemporal control of siRNA/nanoparticle delivery.
    Wang Y; Zhang S; Benoit DSW
    J Control Release; 2018 Oct; 287():58-66. PubMed ID: 30077736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
    Pittella F; Miyata K; Maeda Y; Suma T; Watanabe S; Chen Q; Christie RJ; Osada K; Nishiyama N; Kataoka K
    J Control Release; 2012 Aug; 161(3):868-74. PubMed ID: 22580114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor.
    Fitzgerald KA; Malhotra M; Gooding M; Sallas F; Evans JC; Darcy R; O'Driscoll CM
    Int J Pharm; 2016 Feb; 499(1-2):131-145. PubMed ID: 26721726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy.
    Tang J; Li B; Howard CB; Mahler SM; Thurecht KJ; Wu Y; Huang L; Xu ZP
    Biomaterials; 2019 Sep; 216():119232. PubMed ID: 31195300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid nanoparticles for short interfering RNA delivery.
    Leung AK; Tam YY; Cullis PR
    Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.